vs
Enact Holdings, Inc.（ACT）与Indivior Pharmaceuticals, Inc.（INDV）财务数据对比。点击上方公司名可切换其他公司
Indivior Pharmaceuticals, Inc.的季度营收约是Enact Holdings, Inc.的1.1倍（$357.0M vs $312.1M），Enact Holdings, Inc.净利率更高（53.8% vs 28.9%，领先25.0%）
Enact Holdings, Inc.是美国领先的私人抵押贷款保险服务商，为银行、信用社等各类住宅抵押贷款机构提供风险缓释解决方案，帮助首付较低的购房者获得可负担的住房贷款，助力更多美国普通消费者实现安居需求。
Indivior是一家全球专科制药企业，专注于开发和商业化针对阿片类物质使用障碍、酒精依赖及相关精神健康疾病的循证治疗方案，核心市场覆盖北美与欧洲，旗下多款获批疗法服务于医疗需求未被充分满足的患者群体。
ACT vs INDV — 直观对比
营收规模更大
INDV
是对方的1.1倍
$312.1M
净利率更高
ACT
高出25.0%
28.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $312.1M | $357.0M |
| 净利润 | $168.0M | $103.0M |
| 毛利率 | — | 82.1% |
| 营业利润率 | — | 22.7% |
| 净利率 | 53.8% | 28.9% |
| 营收同比 | 1.7% | — |
| 净利润同比 | 1.2% | 390.5% |
| 每股收益（稀释后） | $1.18 | $0.79 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACTINDV
| Q1 26 | $312.1M | — | ||
| Q4 25 | $312.7M | $357.0M | ||
| Q3 25 | $311.5M | $314.0M | ||
| Q2 25 | $304.9M | $302.0M | ||
| Q1 25 | $306.8M | $266.0M | ||
| Q4 24 | $301.8M | — | ||
| Q3 24 | $309.6M | $307.0M | ||
| Q2 24 | $298.8M | $299.0M |
净利润ACTINDV
| Q1 26 | $168.0M | — | ||
| Q4 25 | — | $103.0M | ||
| Q3 25 | — | $42.0M | ||
| Q2 25 | — | $18.0M | ||
| Q1 25 | — | $47.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $22.0M | ||
| Q2 24 | — | $-97.0M |
毛利率ACTINDV
| Q1 26 | — | — | ||
| Q4 25 | — | 82.1% | ||
| Q3 25 | — | 73.2% | ||
| Q2 25 | — | 82.8% | ||
| Q1 25 | — | 83.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 78.5% | ||
| Q2 24 | — | 73.6% |
营业利润率ACTINDV
| Q1 26 | — | — | ||
| Q4 25 | 71.3% | 22.7% | ||
| Q3 25 | 67.4% | 13.7% | ||
| Q2 25 | 70.4% | 23.8% | ||
| Q1 25 | 68.9% | 24.8% | ||
| Q4 24 | 68.9% | — | ||
| Q3 24 | 74.1% | 11.4% | ||
| Q2 24 | 78.6% | -39.5% |
净利率ACTINDV
| Q1 26 | 53.8% | — | ||
| Q4 25 | — | 28.9% | ||
| Q3 25 | — | 13.4% | ||
| Q2 25 | — | 6.0% | ||
| Q1 25 | — | 17.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 7.2% | ||
| Q2 24 | — | -32.4% |
每股收益（稀释后）ACTINDV
| Q1 26 | $1.18 | — | ||
| Q4 25 | $1.23 | $0.79 | ||
| Q3 25 | $1.10 | $0.33 | ||
| Q2 25 | $1.11 | $0.14 | ||
| Q1 25 | $1.08 | $0.38 | ||
| Q4 24 | $1.05 | — | ||
| Q3 24 | $1.15 | $0.16 | ||
| Q2 24 | $1.16 | $-0.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $549.0M | $195.0M |
| 总债务越低越好 | $744.9M | — |
| 股东权益账面价值 | $5.3B | $-98.0M |
| 总资产 | $7.0B | $1.2B |
| 负债/权益比越低杠杆越低 | 0.14× | — |
8季度趋势，按日历期对齐
现金及短期投资ACTINDV
| Q1 26 | $549.0M | — | ||
| Q4 25 | $582.5M | $195.0M | ||
| Q3 25 | $545.6M | $445.0M | ||
| Q2 25 | $616.0M | $510.0M | ||
| Q1 25 | $639.0M | $373.0M | ||
| Q4 24 | $602.8M | — | ||
| Q3 24 | $674.9M | — | ||
| Q2 24 | $711.3M | — |
总债务ACTINDV
| Q1 26 | $744.9M | — | ||
| Q4 25 | $744.5M | — | ||
| Q3 25 | $744.1M | — | ||
| Q2 25 | $743.8M | — | ||
| Q1 25 | $743.4M | — | ||
| Q4 24 | $743.0M | — | ||
| Q3 24 | $742.7M | — | ||
| Q2 24 | $742.4M | — |
股东权益ACTINDV
| Q1 26 | $5.3B | — | ||
| Q4 25 | $5.4B | $-98.0M | ||
| Q3 25 | $5.3B | $-207.0M | ||
| Q2 25 | $5.2B | $-257.0M | ||
| Q1 25 | $5.1B | $-285.0M | ||
| Q4 24 | $5.0B | — | ||
| Q3 24 | $5.0B | $-310.0M | ||
| Q2 24 | $4.8B | $-281.0M |
总资产ACTINDV
| Q1 26 | $7.0B | — | ||
| Q4 25 | $6.9B | $1.2B | ||
| Q3 25 | $6.9B | $1.4B | ||
| Q2 25 | $6.8B | $1.5B | ||
| Q1 25 | $6.7B | $1.4B | ||
| Q4 24 | $6.5B | — | ||
| Q3 24 | $6.6B | — | ||
| Q2 24 | $6.3B | — |
负债/权益比ACTINDV
| Q1 26 | 0.14× | — | ||
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.14× | — | ||
| Q1 25 | 0.15× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.15× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-221.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-245.0M |
| 自由现金流率自由现金流/营收 | — | -68.6% |
| 资本支出强度资本支出/营收 | — | 6.7% |
| 现金转化率经营现金流/净利润 | — | -2.15× |
| 过去12个月自由现金流最近4个季度 | — | $-93.0M |
8季度趋势，按日历期对齐
经营现金流ACTINDV
| Q1 26 | — | — | ||
| Q4 25 | $724.5M | $-221.0M | ||
| Q3 25 | $192.0M | $-39.0M | ||
| Q2 25 | $119.5M | $158.0M | ||
| Q1 25 | $226.7M | $75.0M | ||
| Q4 24 | $686.3M | — | ||
| Q3 24 | $188.1M | $2.0M | ||
| Q2 24 | $144.7M | $88.0M |
自由现金流ACTINDV
| Q1 26 | — | — | ||
| Q4 25 | — | $-245.0M | ||
| Q3 25 | — | $-59.0M | ||
| Q2 25 | — | $141.0M | ||
| Q1 25 | — | $70.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-5.0M | ||
| Q2 24 | — | $84.0M |
自由现金流率ACTINDV
| Q1 26 | — | — | ||
| Q4 25 | — | -68.6% | ||
| Q3 25 | — | -18.8% | ||
| Q2 25 | — | 46.7% | ||
| Q1 25 | — | 26.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -1.6% | ||
| Q2 24 | — | 28.1% |
资本支出强度ACTINDV
| Q1 26 | — | — | ||
| Q4 25 | — | 6.7% | ||
| Q3 25 | — | 6.4% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 1.3% |
现金转化率ACTINDV
| Q1 26 | — | — | ||
| Q4 25 | — | -2.15× | ||
| Q3 25 | — | -0.93× | ||
| Q2 25 | — | 8.78× | ||
| Q1 25 | — | 1.60× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.09× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACT
| Premiums | $242.8M | 78% |
| Other | $69.2M | 22% |
INDV
| Sublocade | $233.0M | 65% |
| Sublingual And Other | $69.0M | 19% |
| Other | $49.0M | 14% |
| Perseris | $6.0M | 2% |
